This is in contrast to the finding of Huebener et al. reporting a 5-fold increase of infiltrating CD8+ T cells into primary tumors after vaccination with a xenogenic TH-based DNA vaccine 15 days after tumor cell implantation (tumor volume of about 200–400 mm3). The gene discussed is CD8A; the disease is neoplasm.